|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 9 August 2006
doi: 10.1242/dev.02501
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review |
Division of Developmental Neurobiology, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
e-mail: sang{at}nimr.mrc.ac.uk
SUMMARY
Although loss of midbrain dopaminergic neurons is associated with one of the most common human neurological disorders, Parkinson's disease, little is known about the specification of this neuronal subtype. Hence, the recent identification of major transcriptional determinants regulating the development of these neurons has brought much excitement and encouragement to this field. These new findings will help to elucidate the genetic program that promotes the generation of midbrain dopaminergic neurons. Importantly, these discoveries will also significantly advance efforts to differentiate stem cells into midbrain dopaminergic neurons that can be used for therapeutic use in treating Parkinson's disease.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
M. Tang, Y. Miyamoto, and E. J. Huang Multiple roles of {beta}-catenin in controlling the neurogenic niche for midbrain dopamine neurons Development, June 15, 2009; 136(12): 2027 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yin, S. Liu, Y. Yin, S. Li, Z. Li, X. Wu, B. Zhang, S.-L. Ang, Y. Ding, and J. Zhou Ventral Mesencephalon-Enriched Genes That Regulate the Development of Dopaminergic Neurons In Vivo J. Neurosci., April 22, 2009; 29(16): 5170 - 5182. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamauchi, S. Mizushima, A. Tamada, N. Yamamoto, S. Takashima, and F. Murakami FGF8 Signaling Regulates Growth of Midbrain Dopaminergic Axons by Inducing Semaphorin 3F J. Neurosci., April 1, 2009; 29(13): 4044 - 4055. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, N. Yamada, W. Maruyama, and T. Osawa Formation of Dopamine Adducts Derived from Brain Polyunsaturated Fatty Acids: MECHANISM FOR PARKINSON DISEASE J. Biol. Chem., December 12, 2008; 283(50): 34887 - 34895. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. M. Ferri, W. Lin, Y. E. Mavromatakis, J. C. Wang, H. Sasaki, J. A. Whitsett, and S.-L. Ang Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner Development, August 1, 2007; 134(15): 2761 - 2769. [Abstract] [Full Text] [PDF] |
||||